Approach to bone marrow transplantation in which doses of chemotherapy given prior to infusion of new stem cells are of sufficient magnitude to suppress but not entirely ablate host bone marrow hematopoiesis. The intent is to sufficiently suppress host bone marrow function that the new stem cells can efficiently engraft, without so impairing host bone marrow function that the patient becomes markedly susceptible to infection.